Flavivirus and Alphavirus ReVAMPP (FLARE - Research Project 4)

Dr. Scott Weaver will serve as the Project Leader for “Research Project 4: Immunogenicity, efficacy and safety of EILV-vectored vaccines against emerging alphaviruses” at UTMB in support of the U19 FLARE group for all years supported by the U19. Dr. Weaver will ensure data are provided to the FLARE and ReVAMPP Network in a timely manner, including adhering to the new data reporting regulations, annual progress reports, and any interactions with NIAID. RP4 key personnel will participate in regular communications between all institutions.